ASCO GUIDELINES Bundle

Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Brain Metastases

ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1475439

Contents of this Issue

Navigation

Page 7 of 9

Patients with HER2+ metastatic breast cancer with CNS metastasis Received prior treatment? Resectable? Suitable for SRS? Symptomatic? Symptomatic? Poor prognosis No, symptomatic mass effect Patients with ≥5 metastases Yes No Yes No Yes, resectable No BSC, palliative care ± radiation therapy a WBRT/M-HA or SRS if <2 cm without symptoms, potential systemic therapy a WBRT/M- HA ± subsequent SRS or systemic therapy a Resection (of larger lesion) + postoperative RT or SRS ± WBRT (for small symptomatic, resectable metastasis) SRS ± WBRT/M-HA or systemic therapy a SRS ± WBRT/M-HA

Articles in this issue

Archives of this issue

view archives of ASCO GUIDELINES Bundle - Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Brain Metastases